The PES has over 1300 members representing the multiple disciplines of Pediatric Endocrinology. The members are dedicated to research and treatment of children with endocrine disorders; reproductive, bone, thyroid, diabetes, obesity, growth, pituitary and adrenal. The Society works to promote the continuing education of its membership.
Our recent need during these unprecedented times to adjust promptly to Telehealth, in order to continue to care for our patients, comes with many long-term benefits but also several challenges.
To help with some of the most commons challenges and questions we are all facing, we approached our colleagues and PES members Dr. Jennifer Raymond (CHLA) and Dr. Stephanie Crossen (UC Davis) for insights from their multiyear experience in telehealth.
They have both practiced Telehealth for over 6 years and authored multiple articles on the use of telemedicine in pediatric and adolescent diabetes care especially, including this recent article https://www.ncbi.nlm.nih.gov/pubmed/32191141. #TimeToTele "
The PES is advocating for immediate changes to Medicaid, CHIP, and private insurers so that pediatric endocrine practices can provide and be paid for telehealth care services. A letter has been sent to Congress on behalf of the PES asking that all health insurance providers, including employer-sponsored plans regulated by the Employee Retirement Income Security Act and all Medicaid Managed Care Organizations, be required to modify their benefit, coverage and payment policies so that there is parity of reimbursement for virtual care options and in-person visits.
PES has been closely monitoring the rapidly increasing domestic and worldwide developments during the last several weeks, days, and even hours related to COVID-19. Between the fast-growing number of members’ institutions that have implemented travel bans, the President declaring this pandemic a National Emergency, and the city of Fort Worth declaring a Public Health emergency due to COVID-19, it is obvious that all these realities make it impossible to hold the 2020 PES Annual Meeting, originally scheduled for April 24-27, 2020 in Fort Worth, TX.
On October 29, 2019, the PES released the following statement given concerns of misinformation in the media and by some government officials regarding gender affirmative care. Certain legislators have threatened to introduce legislation which would ban use of puberty blockers in transgender youth younger than 18 years, which contradicts the PES supported Endocrine Society guidelines, as well as the guidelines of the American Academy of Pediatrics.
The Pediatric Endocrine Society (PES) hosted the 2019 Board Review Course on April 24-26, 2019 at the Hyatt Regency Baltimore Inner Harbor Hotel in Baltimore, Maryland just prior to the 2019 PAS/PES Annual Meeting. PES is now making the recordings of this course available for purchase. These videos include the speaker's PowerPoint slides synchronized with the audio of the presenters and covers the topics included in the new ABP Pediatric Endocrine Content Outline.
Watch the videos on your own time and watch the videos as many times as you need.
On behalf of The Education Committee of The Pediatric Endocrine Society, we are very pleased to inform the PES membership of a new educational initiative: The "PES Webinar Series".
The webinars are scheduled to be held quarterly. The webinars will be held on the 3rd Monday of January, April, July, and October of 2019/2020 from 4:00 - 5:00 EST.
Please keep an eye out to webinar sign up information in our PES Presidents letters and eblasts.
Click here to watch past webinars and see a schedule of upcoming talks.
The PES Research Affairs Committee receives and reviews surveys three times per year. This allows PES members to provide expert input on educational and practice improvement initiatives and to support research projects of members and members-in-training. Throughout the year, we'd like to highlight the survey results and publications.
Click here to view survey results and publications
© Copyright 2017. Pediatric Endocrine Society. All Rights Reserved.